Demetriades Demetrios G. 4

What Happened
Demetriades Demetrios G., a director and the company secretary of Cosmos Health (COSM), was granted 20,000 restricted stock units (RSUs) on May 19, 2026 that vested immediately and were converted into 20,000 shares of common stock. The grant is reported at $0.28 per share for a stated value of $5,660. The Form 4 shows a simultaneous conversion of the derivative security (the RSUs) into common shares (recorded as a derivative conversion at $0.00).

Key Details

• Transaction date: May 19, 2026 (filed: June 11, 2026) — filing appears late relative to the two-business-day Form 4 rule.
• Grant: 20,000 shares reported as an award/acquisition at $0.28 per share; total reported value $5,660.
• Conversion: 20,000 shares reported as conversion of a derivative security at $0.00 (reflecting the RSUs converting into common stock).
• Shares owned after the transaction: Not disclosed in the information provided.
• Footnotes: F1/F2 state the award was made under the Issuer’s 2024 & 2025 Omnibus Incentive Plan, vested on the date of grant, and the transaction was exempt under Rule 16b-3.

Context
This is a compensation-related award (RSUs that vested on grant) and is commonly part of executive/director pay; such grants are routine and do not by themselves indicate insider buying or selling sentiment. The derivative conversion at $0.00 simply reflects the RSUs converting into shares with no purchase price paid by the insider. The delayed filing date is noteworthy because timely Form 4s help investors track insider activity.